0001209191-23-013301.txt : 20230227
0001209191-23-013301.hdr.sgml : 20230227
20230227172442
ACCESSION NUMBER: 0001209191-23-013301
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230223
FILED AS OF DATE: 20230227
DATE AS OF CHANGE: 20230227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rona Jeffrey A
CENTRAL INDEX KEY: 0001311404
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38085
FILM NUMBER: 23676749
MAIL ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ovid Therapeutics Inc.
CENTRAL INDEX KEY: 0001636651
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465270895
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 212-776-4381
MAIL ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-23
0
0001636651
Ovid Therapeutics Inc.
OVID
0001311404
Rona Jeffrey A
C/O OVID THERAPEUTICS INC.
441 NINTH AVENUE
NEW YORK
NY
10001
0
1
0
0
CBFO
Stock Option (Right to Buy)
2.50
2023-02-23
4
A
0
175000
0.00
A
2033-02-22
Common Stock
175000
175000
D
25% of the shares subject to the Stock Option will vest and become exercisable on February 23, 2024 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.
/s/ Danielle Mann for Jeff Rona by PoA
2023-02-27